NR3C2 and atrial fibrillation: While AF does not appear to modify the effects of angiotensin receptor blockers, sacubitril/valsartan, mineralocorticoid receptor antagonists, or vericiguat in patients with HFrEF,4, 5, 6 patients with AF obtain less benefit from beta‐blockers compared to those without AF.15